University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

iMPACT - Improving Patient Access to Cancer Clinical Trials

iMPACT

Improving Patient Access to Cancer Clinical Trials

Lazarex Cancer Foundation iMPACT

IMPACT is a 3-year pilot study with a comprehensive approach to improving patient enrollment, retention, minority participation and equitable access in oncology trials. UCSF is excited to be one of several institutions participating in this landmark study.  

The iMPACT Study is a pilot study for IMproving Patient Access to cancer Clinical Trials using a sliding scale financial reimbursement program for ancillary expenses associated with clinical trial participation (gas, parking, flights, hotels, Ubers/Lyfts/taxis, rental car, travel companion, etc). All adult cancer patients being considered for a therapeutic clinical trial are eligible. The study is sponsored by the Lazarex Cancer Foundation, a nonprofit charity dedicated to improving patient enrollment, retention, minority participation, and equitable access in oncology trials.  This study is now accruing patients, as of April 2019.

read latest news
read more from Lazarex

 

Latest News

 

About Lazarex

  • Impact Summary Report
    We improve the outcome of cancer care for advanced stage cancer patients and the medically underserved, by providing assistance with costs for FDA clinical trial participation, identification of clinical trial options, community outreach and education. For over a decade, Lazarex Cancer Foundation has uniquely provided these services as a public charity. Read more

 

Press - Governor Brown Sings inot law the California Clinical Trials Program